Edwards EVOQUE Tricuspid Valve Replacement System (9850EV)
Edwards Lifesciences, LLC · Decision date Oct 28, 2026
What did the FDA decide?
The FDA record for P230013/S034 describes a 30-day notice, dated 2026-10-28, with a reported purpose of implementing an alternative supplier of a chemical manufacturing aid. The listed supplement reason is a process change covering manufacturer, sterilizer, packager or supplier. The applicant is Edwards Lifesciences, LLC, and the product code is NPW, in the cardiovascular specialty.
The identifier ties the notice to the original PMA P230013, and the title names the Edwards EVOQUE tricuspid valve replacement system (9850EV). That relationship identifies the affected filing but does not make this supplement a new approval of the whole system, and a manufacturing notice is not an original PMA. The record does not name the chemical manufacturing aid, the prior or replacement supplier, affected lots or models, or any supporting data. The stated purpose is not independent proof of safety or clinical effectiveness, and the record supports no clinical or regulatory conclusion beyond this description.
FDA approval order statement
implementing an alternative supplier of a chemical manufacturing aid
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 28, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P230013/S034
- Regulatory pathway
- PMA supplement
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NPW
- Decision code
- OK30
- Decision date
- Oct 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Percutaneously Delivered Prostheses and Tricuspid Valves.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NPW
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P230013. Subsequent supplements may change the device or its indications.
FDA decision timeline
P230013 · Original PMA
Edwards EVOQUE Tricuspid Valve Replacement System
P230013/S027 · Related supplement
EVOQUE Tricuspid Valve Replacement System
P230013/S034 received
Application receipt date recorded by FDA.
P230013/S029 · Related supplement
Edwards EVOQUE Tricuspid Valve Replacement System
P230013/S033 · Related supplement
EVOQUE Tricuspid Valve Replacement System
P230013/S034 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P230013. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P230013
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA approval | Feb 1, 2024 | FDA | |
EVOQUE Tricuspid Valve Replacement SystemP230013/S027 | Edwards Lifesciences, LLC | PMA supplement | Sep 16, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Oct 19, 2026 | FDA | |
EVOQUE Tricuspid Valve Replacement SystemP230013/S033 | Edwards Lifesciences, LLC | PMA supplement | Oct 21, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P230013/S034
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records